medigraphic.com
SPANISH

Revista ADM Órgano Oficial de la Asociación Dental Mexicana

ISSN 0001-0944 (Print)
Órgano Oficial de la Asociación Dental Mexicana
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2019, Number 2

<< Back Next >>

Rev ADM 2019; 76 (2)

Combined therapy of diode laser and neuromuscular deprogrammer splint in patients with temporomandibular disorder

Sánchez VSI
Full text How to cite this article

Language: Spanish
References: 10
Page: 109-112
PDF size: 250.84 Kb.


Key words:

Temporomandibular disorder, laser therapy, neuromuscular desporgramer.

ABSTRACT

Neuromuscular deprogramming plays an important role in the treatment of temporomandibular dysfunction, one of the main drawbacks is the prolonged period of treatment, which influences the acceptance of the patient or the abandonment of treatment. The diagnosis is crucial to plan the treatment since it covers a wide range of variables to treat it, so in this case it is a dolichofacial patient, with problems of temporomandibular dysfunction of muscular origin, which is why we chose to use low-level laser therapy, level as a coadjutant of treatment, resulting in a better acceptance and collaboration of the deprogramming of the patient in a shorter period of time.


REFERENCES

  1. Sevinc Kulekcioglu, Koncuy Sivrioglu, Orhan Ozcan, Mufit Parlak. Effectiveness of low-level laser therapy in temporomandibular, disorder. Scand J Rheumatol. 2003; 32: 114-118.

  2. Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: review, examinations and specifications criteria. J Craniomandib Disord. 1992; 6: 301-355.

  3. Maria CA, Monica PA, Sever P et al. Factors involved in the etiology of temporomandibular disorders: a literature review. Clujul Med. 2015; 88 (4): 473-478.

  4. Leresche L, Drangsholt M. Epidemiology of orofacial pain: prevalence, incidence, and risk factors. In: Sessle BJ, Lavigne GJ, Lund JP, Dubner R, editors. Orofacial pain. From basic science to clinical management. 2nd ed. Chicago: Quintessence Publishing; 2008. pp. 13-18.

  5. Bertolini SE, Bertolini FM, Kioaki OL. Clinical assessment of the efficacy of low-level laser therapy on muscle pain in women with temporomandibular dysfunction, by surface electromyography. Brazilian Journal of Oral Sciences. 2010; 9 (4): 434-438.

  6. Maglione OH, Laraudo J, De Zavaleta L. En: Maglione OH, director. Técnicas para la confaccio de dispositivos oclusales. AMOLCA: Buenos Aires, Argentina; 2008. pp. 195, 196.

  7. Chen J, Huang Z, Ge M, Gao M. Efficacy of low-level laser therapy in the treatment of TMDs: a meta-analysis of 14 randomised controlled trials. J Oral Rehabil. 2015; 42 (4): 291-299.

  8. Gremillion HA. The prevalence and etiology of temporomandibular disorders and orofacial pain. Tex Dent J. 2000; 117: 30-39.

  9. Conti PC. Low level laser therapy in the treatment of temporomandibular disorders (TMD): a double-blind pilot study. Cranio. 1997; 15 (2): 144-149.

  10. González PL, Infante CP, Granados NM. Evidencia científica sobre el diagnóstico y tratamiento de los trastornos temporomandibulares. Revista del Ilustre Consejo General de Colegios de Odontólogos y Estomatólogos de España. 2013; 18 (1): 25-32.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev ADM. 2019;76